Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 69,261 - 69,280 results of 69,884 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.27s Refine Results
  1. 69261
    C−O Coupling of LPt<sup>IV</sup>Me(OH)X Complexes in Water (X = <sup>18</sup>OH, OH, OMe; L = di(2-pyridyl)methane sulfonate)

    C−O Coupling of LPt<sup>IV</sup>Me(OH)X Complexes in Water (X = <sup>18</sup>OH, OH, OMe; L = di(2-pyridyl)methane sulfonate) by Julia R. Khusnutdinova (1619044)

    Published 2020
    Save to List
    Saved in:
  2. 69262
    Table_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.xlsx

    Table_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.xlsx by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  3. 69263
    DataSheet_1_GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis.pdf

    DataSheet_1_GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis.pdf by Xiaomiao Ye (13850284)

    Published 2022
    “…Moreover, compared with WT mice, GSDMD<sup>-/-</sup> mice showed reduced infarct size (25.45 ± 3.07% versus 36.47 ± 3.72%), improved left ventricular ejection fraction (37.71 ± 1.81% versus 29.44 ± 2.28%) and left ventricular fractional shortening (18.01 ± 0.97% versus 13.62 ± 1.15%) as well as attenuated pathological damage after I/R injury, along with reduced levels of proinflammatory cytokines and decreased infiltration of neutrophils.…”
    Save to List
    Saved in:
  4. 69264
    Image_3_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_3_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  5. 69265
    Image_6_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_6_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  6. 69266
    Image_2_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_2_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  7. 69267
    Image_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  8. 69268
    Image_5_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_5_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  9. 69269
    Image_4_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg

    Image_4_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”
    Save to List
    Saved in:
  10. 69270
    Image_8.tif

    Image_8.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  11. 69271
    Image_1.tif

    Image_1.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  12. 69272
    Image_5.tif

    Image_5.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  13. 69273
    Image_3.tif

    Image_3.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  14. 69274
    Image_9.tif

    Image_9.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  15. 69275
    Image_2.tif

    Image_2.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  16. 69276
    Image_6.tif

    Image_6.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  17. 69277
    Image_4.tif

    Image_4.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  18. 69278
    Data_Sheet_1.docx

    Data_Sheet_1.docx by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  19. 69279
    Image_7.tif

    Image_7.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”
    Save to List
    Saved in:
  20. 69280
    Image_3_Transcriptome Analysis of Effects of Folic Acid Supplement on Gene Expression in Liver of Broiler Chickens.pdf

    Image_3_Transcriptome Analysis of Effects of Folic Acid Supplement on Gene Expression in Liver of Broiler Chickens.pdf by Yujie Zhang (399434)

    Published 2021
    “…Finally, contents of LPL, PPARγ, and FAS in abdominal fat were decreased with the folic acid supplmented diets (P < 0.01). …”
    Save to List
    Saved in:

Search Tools: